9th Annual Biomarkers Congress
Transmissible Spongiform Encephalopathies
Excelsior Hotel Ernst
Trankgasse 1-5 / Domplatz,
Cologne,, Germany
http://www.informa-ls.com/tse
Transmissible Spongiform Encephalopathies
http://www.informa-ls.com/tse
Excelsior Hotel Ernst,


Schedule of Presentations:

Thursday, June 25, 2009
05:50:00 Announcements
08:00:00 Registration and morning coffee
09:00:00 Chairperson’s opening remarks Albrecht Groner
09:05:00 Case study on assessing the risk of TSE transmission with focus on plasma derivatives Case study Albrecht Groner
09:40:00 TSE Risk assessment for vaccines: a biotech industry perspective Irene Fiaschi
10:15:00 Case study on assessing the TSE risk in the manufacture of biopharmaceutical products Anne Stokes
10:50:00 Morning coffee and exhibition viewing time
11:20:00 TSE risk perception in Europe – Lessons to learn for better risk communication Kerstin Dressel
11:55:00 Update on the TSE guidelines and regulations in Europe and around the world Jan Schaefer
12:30:00 vCJD blood screening assays: regulatory and ethical perspective Micha Nubling
13:05:00 Lunch and exhibition viewing time
14:15:00 Industry case study under current regulatory guidance: Key considerations for performing TSE clearance studies Kang Cai
14:50:00 Detection methods for prions in spiked intermediates and final samples of manufacturing process steps for evaluation of the prion reduction capacity Albrecht Groner
15:25:00 Afternoon tea and exhibition viewing time
16:00:00 Effective decontamination of prion infectivity and rapid validation by in vitro and cell-based methods Graham S Jackson
16:30:00 Prion protein structure Alastair Aitken
17:05:00 BSE evolution through species barrier crossing and how this may affect the industry Juan Maria Torres
17:40:00 Closing remarks from chairperson Albrecht Groner
17:45:00 End of conference day one
Friday, June 26, 2009
08:30:00 Morning coffee
09:00:00 Chairperson’s opening remarks Albrecht Groner
09:05:00 Case study on the implementation of a novel prion protein removal technology into the manufacturing process of a human plasma product – Octaplas® Andrea Neisser-Svae
09:40:00 Update on the copper-hydrogen peroxide based decontamination procedures: A full decontamination procedure that works for both conventional and prion infectious agents Sylvain Lehmann
10:15:00 Removal and detection of prions in body fluids Ralph Zahn
10:50:00 Morning coffee and exhibition viewing time
11:20:00 Assessment of in-vitro tests for prion decontamination and inactivation Thorsten Kuczius
11:55:00 The validation of prion inactivation and removal processes; challenges for the standardisation of bioassay models J. Mark Sutton
12:30:00 Infectivity and abnormal prion protein in edible tissues: bioassay vs lab detection Francesca Chianini
13:05:00 Lunch and exhibition viewing time
14:15:00 Variant CJD: trends and transmission Robert Will
14:50:00 Investigation of selectively oriented prions surface confined by atomic force microscopy Giuseppe Legname
15:25:00 Afternoon tea and exhibition viewing time
16:00:00 Temporary depletion of CD11c+ dendritic cells delays lymphoinvasion after intraperitonal scrapie infection Joëlle Chabry
16:30:00 PrPSc - Misfolding and what else? Maria Gasset
17:05:00 Closing remarks from chairperson Albrecht Groner
17:10:00 End of conference day two
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.